Free Trial

Pacira BioSciences (PCRX) SEC Filings & 10K Form

Pacira BioSciences logo
$27.18 -0.04 (-0.15%)
Closing price 04:00 PM Eastern
Extended Trading
$27.18 +0.00 (+0.02%)
As of 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Pacira BioSciences SEC Filings

DateFilerForm TypeView
08/08/2025
12:26 PM
Doma Perpetual Capital Management LLC (Filed by)
Pacira BioSciences (Subject)
Form SCHEDULE 13D
08/05/2025
4:19 PM
Pacira BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/05/2025
3:01 PM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025
3:31 PM
Pacira BioSciences (Issuer)
SLONIN JONATHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2025
6:35 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
7:00 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
3:17 PM
Brege Laura (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:17 PM
Pacira BioSciences (Issuer)
Young Alethia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:17 PM
CHRISTIE CHRISTOPHER (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:17 PM
Pacira BioSciences (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:18 PM
BIGAL MARCELO (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:18 PM
Froimson Mark (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:18 PM
Ceesay Abraham (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:18 PM
Kronenfeld Mark A. (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
4:40 PM
Pacira BioSciences (Issuer)
RIKER LAUREN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
4:37 PM
Pacira BioSciences (Issuer)
SLONIN JONATHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
4:37 PM
Pacira BioSciences (Issuer)
WILLIAMS KRISTEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
10:36 AM
Pacira BioSciences (Subject)
RIKER LAUREN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2025
9:37 AM
Pacira BioSciences (Subject)
WILLIAMS KRISTEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2025
10:16 AM
Pacer Advisors, Inc. (Filed by)
Pacira BioSciences (Subject)
Form SCHEDULE 13G/A
05/02/2025
9:44 AM
Pacer Advisors, Inc. (Filed by)
Pacira BioSciences (Subject)
Form SCHEDULE 13G
04/29/2025
3:11 PM
Pacira BioSciences (Filer)
Form DEFA14A
04/29/2025
3:14 PM
Pacira BioSciences (Filer)
Form ARS
04/28/2025
11:17 AM
BlackRock, Inc. (Filed by)
Pacira BioSciences (Subject)
Form SCHEDULE 13G/A
04/22/2025
7:59 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
4:21 PM
Pacira BioSciences (Filer)
Form DEFA14A
03/14/2025
4:26 PM
Pacira BioSciences (Filer)
Form DEFA14A
03/14/2025
4:28 PM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
11:06 AM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
5:25 PM
Pacira BioSciences (Issuer)
RIKER LAUREN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:25 PM
Pacira BioSciences (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:25 PM
Lee Frank D. (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:25 PM
Pacira BioSciences (Issuer)
WILLIAMS KRISTEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:26 PM
Pacira BioSciences (Issuer)
SLONIN JONATHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
7:01 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
7:05 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:30 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Pacira BioSciences (Subject)
Form SCHEDULE 13G
01/10/2025
7:01 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
5:22 PM
Pacira BioSciences (Issuer)
RIKER LAUREN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:22 PM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:23 PM
Pacira BioSciences (Issuer)
SLONIN JONATHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Why Trump’s “Smart Dollar” could rewrite the rules (Ad)

MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel

Get the three steps to take this month to put yourself on the right side of this $30 trillion money
01/06/2025
5:23 PM
Lee Frank D. (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
10:11 AM
Pacira BioSciences (Subject)
SLONIN JONATHAN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:13 PM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
8:41 AM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
8:48 AM
Doma Perpetual Capital Management LLC (Filed by)
Pacira BioSciences (Subject)
Form DFAN14A
10/23/2024
5:54 PM
Cross Shawn (Reporting)
Pacira BioSciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/21/2024
7:04 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
7:02 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
7:29 PM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
9:17 AM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PCRX) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners